The claims include, “Source of antioxidant probiotic” and “Source of antioxidant probiotic in elite athletes.”
Photo © iStockphoto.com/peepo
Lallemand Health Solutions’ (Mirabel, Canada) L. helveticus Lafti L10 probiotic strain received approval from Health Canada to use antioxidant probiotic health claims with an emphasis on athletes. The claims include, “Source of antioxidant probiotic” and “Source of antioxidant probiotic in elite athletes.” These claims are an addition to the previously approved claims that it promotes gastrointestinal comfort in athletes and boosts natural defenses in physically active adults.
“L. helveticus Lafti L10 is already our most recommended strain for sport nutrition due to its previous results on athletes immune and gut health. We had reason to believe its antioxidant potential was strong enough to gain further health claims,” Solange Henoud, global regulatory affairs director at Lallemand Health Solutions, said in a press release. ‘’Moreover, we think this one has been is the first probiotic to be approved as a source of antioxidant.”
These claims are supported by a recent post-hoc paper published in the Journal of Human Kinetics that included 22 elite althletes. At the end of the study, significant attenuation of the markers of oxidative stress (MDA) and levels of advanced oxidation protein products (AOPP) and an increase in the marker of defense against oxidative stress (SOD) were observed in the LAFTI L10 group and not in the placebo group.
Reference
Michalickova D et al. “Effects of probiotic supplementation on selected parameters of blood prooxidant-antioxidant balance in elite athletes: a double-blind randomized placebo-controlled study.” Journal of Human Kinetics, vol. 64 (2018): 111-122
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.